Current status of the hormone therapy during the menopausal transition ans post-menopausa

Starting from prospectivc clinical stuclics that have evaluated its benefits and risks, hormotie replacement therapy in rnenopause wornen has been reassessecl in its indications  in the last four years. In October, 2004 a Latinarnerican Experts Consensus was carried out,  such repo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Figueroa Casas, Pedro R
Formato: Artículo revista
Lenguaje:Español
Publicado: Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2021
Materias:
.
Acceso en línea:https://revistas.unc.edu.ar/index.php/med/article/view/27899
Aporte de:
id I10-R10article-27899
record_format ojs
institution Universidad Nacional de Córdoba
institution_str I-10
repository_str R-10
container_title_str Revistas de la UNC
language Español
format Artículo revista
topic .
spellingShingle .
Figueroa Casas, Pedro R
Current status of the hormone therapy during the menopausal transition ans post-menopausa
topic_facet .
author Figueroa Casas, Pedro R
author_facet Figueroa Casas, Pedro R
author_sort Figueroa Casas, Pedro R
title Current status of the hormone therapy during the menopausal transition ans post-menopausa
title_short Current status of the hormone therapy during the menopausal transition ans post-menopausa
title_full Current status of the hormone therapy during the menopausal transition ans post-menopausa
title_fullStr Current status of the hormone therapy during the menopausal transition ans post-menopausa
title_full_unstemmed Current status of the hormone therapy during the menopausal transition ans post-menopausa
title_sort current status of the hormone therapy during the menopausal transition ans post-menopausa
description Starting from prospectivc clinical stuclics that have evaluated its benefits and risks, hormotie replacement therapy in rnenopause wornen has been reassessecl in its indications  in the last four years. In October, 2004 a Latinarnerican Experts Consensus was carried out,  such report with sorne modifications is presented in this publication. The conclusions the  experts reached were the foliowing: 1) Hormone Therapy is the goid standard for the  control of moderate to severe vasomotor symptorns; 2) this therapy mut be inclicated in an individual manner and only in syrnptomatic women in which the henefit is greater than the  risk; 3) the Ieast effective dose rnust be used; 4) it rnust he used neither for cardiovascular  prevention, osteoporosis, colon cancer nor for mental disorder; 5) the patient must be  informed about the benefits and risks.  
publisher Universidad Nacional Cba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
publishDate 2021
url https://revistas.unc.edu.ar/index.php/med/article/view/27899
work_keys_str_mv AT figueroacasaspedror currentstatusofthehormonetherapyduringthemenopausaltransitionanspostmenopausa
AT figueroacasaspedror terapiahormonalenlatransicionalamenopausiayenlaposmenopausiaestadoactual
bdutipo_str Revistas
_version_ 1764819782184468482